-
Leading Pediatric Cancer Center Selects Petagene’s Genomic Data Compression Solutions for Informatics Infrastructure
Oct 22, 2019, 07:28 AM by Michael CroftCAMBRIDGE, UK - Oct 22, 2019 - PetaGene today announced that Princess Máxima Center for Pediatric Oncology, the largest pediatric cancer center in Europe, has chosen to use PetaGenes transparent, lossless genomic data compression software, called PetaSuite, to reduce its data storage costs while accelerating access to the dataFull story -
As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
Oct 22, 2019, 06:28 AM by Michael CroftKING OF PRUSSIA, PA - Oct 22, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractorsFull story -
A New Marketplace For Machine Learning Researchers—And Citizen Scientists
Oct 22, 2019, 06:00 AM by Michael CroftFull storyBio-IT World | A nonprofit devoted to citizen science has been working with biomedical researchers at Cornell University to apply crowd power and artificial intelligence (AI) to questions neither humans nor machines could answer alone.
-
Enhancing ZEISS Celldiscoverer 7 with ZEISS LSM 900 for optical sectioning
Oct 21, 2019, 12:06 PM by Michael Croft- Oct 21, 2019 - The proven ZEISS Celldiscoverer 7 is a fully integrated high-end imaging system with various incubation and detection optionsFull story -
UKI2S Innovate Accelerator reaches entrepreneurial start-ups in all parts of the UK
Oct 21, 2019, 05:27 AM by Michael CroftLONDON, UK - Oct 21, 2019 - Sciad Newswire / The UK Innovation & Science Seed Fund (UKI2S) has celebrated the first anniversary of its UKI2S Innovate Accelerator, a joint funding initiative with Innovate UK (IUK) directed at early stage science and engineering companiesFull story -
MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform
Oct 18, 2019, 17:19 PM by Michael CroftHOUSTON, TX, UNITED STATES - Oct 18, 2019 - MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS)Full story -
PetaGene announces collaboration with AstraZeneca to deploy its genomic data compression software in core genomics initiative
Oct 18, 2019, 08:17 AM by Michael CroftCAMBRIDGE, UK - Oct 18, 2019 - PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZenecas Centre for Genomics Research (CGR)Full story -
Consent and Privacy Policy Updates From GA4GH
Oct 18, 2019, 06:15 AM by Michael CroftFull storyBio-IT World | Last month the Regulatory and Ethics Work Stream of the Global Alliance for Genomics in Health shared revised regulatory and ethics policies.
-
Amplion's Machine Learning Platform Accelerates Precision Medicine Collaboration
Oct 16, 2019, 13:13 PM by Michael CroftBEND, OR, UNITED STATES - Oct 16, 2019 - - Effective partnerships between pharmaceutical companies, biotechs, academia, diagnostic companies, CROs and other players along the drug development continuum are vital to achieving the realization of precision medicine- For diagnostic and test providers in particular, identifying the right pharma partnering opportunities at the right time can be daunting, yet it's critical for gaining early traction and establishing long-term profitable relationships- Amplion's Dx:Revenue solution plays an important role in aiding test providers in finding and targeting these elusive pharma partnering opportunities through relevant and timely insightsAmplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaborationFull story -
BioIVT Acquires PPA Research Group, Increasing its Ability to Support Drug Development, Cell and Gene Therapy Research
Oct 16, 2019, 08:32 AM by Michael CroftWESTBURY, NY - Oct 16, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, IncFull story -
Magnetic Cell Sorting + CRISPR = Faster Drug Discovery
Oct 16, 2019, 08:05 AM by Michael CroftFull storyBio-IT World | A microfluidics device that uses magnetic labeling to sort one billion cells per hour, based on their molecular makeup, has the attention of biotechnology and pharmaceutical companies hungry for data on their favorite drug targets.
-
iGenomX Launches Next-Generation Genotyping Application to Propel the Future of Population-Scale Genomics Research
Oct 15, 2019, 10:04 AM by Michael CroftHOUSTON, TX, UNITED STATES - Oct 15, 2019 - iGenomX International Genomics Corp., provider of the industrys most scalable sequencing library tools, today launched its Next-Generation Genotyping (NGG) application for population-scale genomic researchFull story -
Why Bioprocessing 4.0 Is A Force To Be Reckoned With
Oct 15, 2019, 07:05 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Whether you're ready or not, the fourth industrial revolution is on its way. Not just a funky new buzzword, "Industry 4.0" refers to a new approach to manufacturing that we can't afford to ignore – bioprocessing engineers included.
-
The University of Bristol Selects Signant Health’s TrialConsent® to Assess the Impact and Value of eConsent in an Oncology Trial
Oct 14, 2019, 09:12 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Oct 14, 2019 - The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has selected Signant Health, formerly CRF Health and Bracket, as its partner to provide electronic informed consent (eConsent) support for an oncology trialFull story -
New AI Model Predicts Clinical Translation Of Biomedical Research
Oct 11, 2019, 07:50 AM by Michael CroftFull storyBio-IT World | The US National Institutes of Health's Office of Portfolio Analysis has developed a machine learning model that predicts whether a scientific advance is likely to translate to the clinic.
-
Alfa Chemistry Announced to offer Surfactant Products
Oct 10, 2019, 23:52 PM by Michael CroftNEW YORK, NY - Oct 1, 2019 - On September 25, 2019, Alfa Chemistry, a well known New York-based chemical supplier, announced to enlarge its product lines by offering a wide range of surfactant products to their customersFull story -
Physician Support Organization Health Plus Management Announces Appointments for Two Key Leadership Positions
Oct 10, 2019, 12:23 PM by Michael CroftUNIONDALE, NY, NY, UNITED STATES - Oct 10, 2019 - UNIONDALE, N.Y.--(BUSINESS WIRE)--Health Plus Management, a physician support organization (PSO) providing business management and operations services for independent physician practices specializing in musculoskeletal care, today announced the appointment of Scott Asher as Chief Development Officer, and Claudia Hinrichsen, EsqFull story -
Optibrium introduces Augmented Chemistry™ services to guide successful drug discovery
Oct 10, 2019, 11:31 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Oct 10, 2019 - Optibrium, a developer of software for drug discovery, today announced the introduction of its Augmented Chemistry services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and advance their drug discovery projectsFull story -
Scientists at the MDI Biological Laboratory Are Decoding the Genetic Mechanisms of Aging
Oct 10, 2019, 10:01 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Oct 10, 2019 - The discovery in the 1990s that a mutation in a single gene of an experimental worm could double its lifespan set off a stampede of research on the molecular biology of aging and triggered hopes that drug therapies or other interventions could be developed to extend healthy human lifespanFull story -
Irish Clinical Research Team Selects Shimmer’s Verisense Continuous Monitoring Platform to Study Breast Cancer-related Fatigue
Oct 10, 2019, 08:17 AM by Michael CroftCAMBRIDGE, MA - Oct 10, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that a team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) will be using Shimmers Verisense continuous monitoring platform to study fatigue accurately in individuals with breast cancerFull story